EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

Natalie J Nokoff iD, Cindy Buchanan, Jennifer M Barker

The Journal of Clinical Endocrinology & Metabolism · 21.01.2025 · 110 (Supplement_1) · S13-S24

DOI: 10.1210/clinem/dgae563 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 21.01.2025. Verfasst von Natalie J Nokoff und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most common form of congenital adrenal hyperplasia (CAH) is secondary to 21-hydroxylase deficiency (21OHD). This review will summarize the clinical manifestations, recommended treatments, monitoring, clinical challenges and management strategy, and treatment challenges in special situations for infants and children with classic CAH due to 21OHD. Specifically, we review newborn screening and the initial diagnosis, glucocorticoid and mineralocorticoid treatment, and recommended monitoring, including anthropometric and laboratory measures. Children with CAH may have premature adrenarche, precocious puberty, and early growth plate closure and have an increased risk of hypertension and overweight/obesity. Many 46,XX individuals will also have genital differences, which may include clitoromegaly and/or a urogenital sinus. We review psychosocial and surgical considerations, including suggestions on how to talk with children, family, and caregivers about bodily difference. These suggestions may be used by families and/or providers caring for individuals with CAH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Hyperplasia, CongenitalHumansChildInfantInfant, NewbornNeonatal ScreeningFemaleGlucocorticoidsChild, PreschoolMaleMineralocorticoids

Stichwörter der Autor:innen

17-hydroxyprogesterone21-hydroxylase deficiencycongenital adrenal hyperplasiafludrocortisonehydrocortisone

Substanzen

GlucocorticoidsMineralocorticoids

Autor:innen und Institutionen

  • Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Ludeman Family Center for Women's Health Research, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

ORCID-Profile: Natalie J Nokoff

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Nokoff, N. J., Buchanan, C., & Barker, J. M. (2025). Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. The Journal of Clinical Endocrinology & Metabolism, 110(Supplement_1), S13-S24. https://doi.org/10.1210/clinem/dgae563

Vancouver

Nokoff NJ, Buchanan C, Barker JM. Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. The Journal of Clinical Endocrinology & Metabolism. 2025;110(Supplement_1):S13-S24. doi:10.1210/clinem/dgae563

BibTeX
@article{Nokoff2025,
  author = {Nokoff, Natalie J and Buchanan, Cindy and Barker, Jennifer M},
  title = {Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {Supplement_1},
  pages = {S13--S24},
  doi = {10.1210/clinem/dgae563}
}
Kostenlos starten →